Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
25.24
-0.71 (-2.74%)
May 9, 2025, 2:45 PM CST
Cabio Biotech (Wuhan) Company Description
Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers.
Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields.
The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.
Cabio Biotech (Wuhan) Co., Ltd.
Country | China |
Founded | 1999 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 565 |
CEO | Dewei Yi |
Contact Details
Address: No. 999 high-tech Avenue Wuhan, 430073 China | |
Phone | 86 27 6784 5351 |
Website | cabio.cn |
Stock Details
Ticker Symbol | 688089 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100005X31 |
SIC Code | 2890 |
Key Executives
Name | Position |
---|---|
Dewei Yi | Chairman and GM |
Huabiao Wang | Financial Director and Director |
Huarong Yi | Deputy GM and Secretary of the Board of Directors |
Anfeng Geng | Deputy General Manager |
Zhiming Wang | Deputy General Manager |
Xiangyu Li | Deputy General Manager |
Tao Ma | Deputy General Manager |
Hao Xiong | Accounting Supervisor |